Clinical Trials
All Clinical Trials - Page 14 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06648031Phase 1Completed
Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants
Tirzepatide
- NCT06700538Phase 1/Phase 2Recruiting
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Tirzepatide
- NCT06683066Phase 1Recruiting
Study on Human Bioequivalence of Triprerelin Acetate for Injection
Gonadorelin
- NCT06719011Phase 1Completed
A Study on How NNC0174-1213 Works in People With Overweight or Obesity.
Cagrilintide
- NCT06716307Phase 1Completed
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
Semaglutide
- NCT06821100Phase 1Recruiting
Thymalfasin (Thymosin Alpha 1; Ta1) as an Enhancer of Vaccine Response Among Older Adults Receiving Booster Doses of COVID-19 Vaccine
Thymosin-Alpha-1
- NCT06881628Phase 4Recruiting
Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients
Octreotide
- NCT06387199Phase 2/Phase 3Recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
Semaglutide
- NCT07199894Phase 3Recruiting
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Desmopressin
- NCT06517212Phase 2Recruiting
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Tirzepatide
- NCT07717814Phase 1Completed
A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or Obesity
Maridebart-Cafraglutide
- NCT07370922Phase 2Completed
Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia
Dulaglutide
- NCT06191848Phase 4Active Not Recruiting
Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
Tirzepatide
- NCT07018544N/AEnrolling By Invitation
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea
Semaglutide
- NCT06361238Phase 3Recruiting
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Liraglutide
- NCT06672939Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Orforglipron
- NCT06672549Phase 3Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Orforglipron
- NCT06761703N/ACompleted
A Study to Determine the Feasibility of Online Recruitment of People Using an Anti-Obesity Medication for Weight Loss
Tirzepatide
- NCT06632457Phase 3Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Survodutide
- NCT06246799Phase 3Recruiting
Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes
Tirzepatide
- NCT06660173Phase 2Active Not Recruiting
A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)
Maridebart-Cafraglutide
- NCT06534411Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Tirzepatide
- NCT06662383Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Retatrutide
- NCT06779929N/ACompleted
Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Tirzepatide
- NCT06467604N/AActive Not Recruiting
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
Tirzepatide
- NCT06616961Phase 3Not Yet Recruiting
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
Semaglutide
- NCT05202353Phase 1Active Not Recruiting
A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
Semaglutide
- NCT06771128N/ACompleted
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06162715Phase 2/Phase 3Active Not Recruiting
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Tirzepatide
- NCT06518837Phase 2Recruiting
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
Tirzepatide
- NCT07400783N/ARecruiting
TED_ORG: Study on Short Bowel Syndrome
Teduglutide
- NCT06644040Phase 1Completed
A Study of TeriQ Patch in Healthy Adult Female Participants
Teriparatide
- NCT06659679N/ACompleted
Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims
Semaglutide
- NCT06659718N/ACompleted
Emulation of the SOUL Diabetes Trial in Healthcare Claims
Semaglutide
- NCT06659744N/ACompleted
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
Semaglutide
- NCT06649045Phase 3Completed
A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Orforglipron
- NCT06643728Phase 2Active Not Recruiting
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight
Tirzepatide
- NCT06818292N/ACompleted
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
Liraglutide
- NCT06519656Phase 1/Phase 2Completed
Efficacy of Mazdutide for Treating PCOS
Mazdutide
- NCT06596135Phase 3Completed
Open-Label Extension Study of Setmelanotide
Setmelanotide
- NCT06642584Phase 1Completed
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
Semaglutide
- NCT06607926N/AUnknown
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
Thymosin-Alpha-1
- NCT06888167N/ARecruiting
Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.
Exenatide
- NCT06632444Phase 3Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Survodutide
- NCT06345079Phase 2Recruiting
Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
Octreotide
- NCT06575738Phase 1Recruiting
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
Tirzepatide
- NCT06635057Phase 4Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Tirzepatide
- NCT06348264Phase 2Recruiting
Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
Gonadorelin
- NCT06500143N/ACompleted
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
Semaglutide
- NCT06579105Phase 2Completed
Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
Semaglutide